請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54955
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 簡國龍(Kuo-Liong Chien) | |
dc.contributor.author | Yung-Cheng Chen | en |
dc.contributor.author | 陳永崢 | zh_TW |
dc.date.accessioned | 2021-06-16T03:42:35Z | - |
dc.date.available | 2015-03-12 | |
dc.date.copyright | 2015-03-12 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-02-11 | |
dc.identifier.citation | 1.Ahmed S, Cannon CP, Giugliano RP, Murphy SA, Morrow DA, Antman EM, Braunwald E, Gibson CM. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes.Int J Cardiol. 2008;17:131 (1):105-112.
2.Anavekar NS1, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.N Engl J Med. 2004;23:351 (13):1285-1295. 3.Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39(7):1113-1119. 4.Brogan GX Jr, Peterson ED, Mulgund J, Bhatt DL, Ohman EM, GiblerWB, Pollack CV Jr, Farkouh ME, Roe MT. Treatment disparities in thecare of patients with and without diabetes presenting with non-STsegmentelevation acute coronary syndromes. Diabetes Care. 2006;29:9-14. 5.Chang A, Kramer H. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.Nephron Clin Pract. 2011;119(2):171-177. 6.Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT.Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.Lancet. 2010;12,375 (9731):2073-2081. 7.Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16 (1):31-41. 8.Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006;296(11):1377-1384. 9.Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42(4):677-684. 10.Ducloux D, Motte G, Challier B, Gibey R, Chalopin JM. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol. 2000;11(1):134-137. 11.Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM; GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. ArchIntern Med.2004; 164:1457-1463. 12.Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S254-S258. 13.Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG, Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012;380(9854):1662-1673. 14.Freeman RV, Mehta RH, A Badr W, Cooper JV, Kline-Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol. 2003;41(5):718-724. 15.Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB. Renal insufficiencyas a predictor of cardiovascular outcomes and mortality inelderly individuals. JAm Coll Cardiol 2003;41:1364-1372. 16.Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489-495. 17.Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol. 1993;21:920-925. 18.Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortalityfrom coronary heart disease in subjects with type 2 diabetes and innondiabetic subjects with and without prior myocardial infarction.N Engl J Med. 1998;339:229 -234. 19.Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand.1988;224:31-38. 20.Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care.1979;2:120-126. 21.Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.J Am Soc Nephrol. 2004;15(3):538-548. 22.Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC, Chronic Kidney Disease Prognosis Consortium. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.Lancet. 2012;380(9854):1649-1661. 23.Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, PiegasL, Calvin J, Keltai M, Budaj A. Impact of diabetes on long-termprognosis in patients with unstable angina and non-Q-wave myocardialinfarction: results of the OASIS (Organization to Assess Strategies forIschemic Syndromes) Registry. Circulation. 2000;102:1014-1019. 24.Mak KH,Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, Califf RM, Topol EJ. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol.1997; 30:171-179. 25.Patel UD, Young EW, Ojo AO, Hayward RA. CKD progression and mortality among older patients with diabetes. Am J Kidney Dis. 2005;46(3):406-414. 26.Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Effect of kidney disease on acute coronary syndrome. Clin J Am Soc Nephrol. 2010;5 (8):1530-1536. 27.Roffi M, Chew DP, Mukherjee D, Bhatt DL, White JA, Heeschen C,Hamm CW, Moliterno DJ, Califf RM, White HD, Kleiman NS, The’rouxP, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality indiabetic patients with non-ST-segment-elevation acute coronary syndromes.Circulation. 2001;104:2767-2771. 28.Saltzman AJ, Stone GW, Claessen BE, Narula A, Leon-Reyes S, Weisz G, Brodie B, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Metzger DC,Lansky AJ, Nikolsky E, Dangas GD, Mehran R. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.JACC Cardiovasc Interv. 2011;4 (9):1011-1019. 29.Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol. 1988; 62:665-659. 30.Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD; Heart and Estrogen/Progestin Replacement Study (HERS) Investigators.Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?Am J Kidney Dis. 2004;43(1):37-44. 31.Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049-2060. 32.Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005;293(14):1737-1745. 33.Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM.Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective.Am J Kidney Dis. 2006;47(3):378-384. 34.Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol.1989; 14:49-57. 35.Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease Network. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011;154(1):12-21. 36.UNITED STATES RENAL DATA SYSTEM (http://www.usrds.org/). 2014/12/20. 37.U S Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011. (http://www.usrds.org/adr.htm).2014/12/20 38.van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, Chronic Kidney Disease Prognosis Consortium, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.Kidney Int. 2011;79(12):1341-1352. 39.Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE.Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.J Am Soc Nephrol. 2004;15 (5):1316-1322. 40.Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF.All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.Lancet. 2008;28:371 (9631):2173-2182. 41.Webster MW, Scott RS. What cardiologists need to know aboutdiabetes. Lancet. 1997;350(suppl 1):SI23–SI28. 42.Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.Chronic kidney disease as a risk factor for cardiovascular disease and allcause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315. 43.Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardialinfarction: the GUSTO-I experience. J Am Coll Cardiol. 1996;28(7):1661-1669. 44.Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol. 1993;22:1788-1794. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54955 | - |
dc.description.abstract | 背景:本研究將探討有無合併糖尿病與慢性腎臟疾病,對急性心肌梗塞病人短期及長期預後之影響。
方法:此為前瞻性世代研究,在亞東紀念醫院心臟內科進行,由心臟科專責研究助理與專科護理師依據病歷記錄建立資料庫,每月定期由專責心臟專科主治醫師進行品質管控。本研究針對糖尿病與慢性腎臟疾病進行分層分析,比較兩種疾病對短期(三十天)及長期(兩年)預後的影響。分析方法採單變量分析後再以Cox比例風險模式(Cox proportional hazards model)對共變因子做迴歸分析。 結果:2005年至2013年本資料庫共收納2259位急性心肌梗塞確診病患,平均追蹤1.69 ± 0.23年。單變數分析顯示,慢性腎臟疾病對於三十天預後的風險比值(adjusted hazard ratio)為2.11(95%信賴區間為1.66-2.69),兩年預後為6.07(95%信賴區間為4.67-7.92);糖尿病的三十天預後之風險比值為1.81(95%信賴區間為1.33-2.46),兩年預後為2.11(95%信賴區間為1.66-2.69),均達統計顯著意義。其他包括吸菸、高血壓、心房纖維顫動、冠狀動脈疾病或中風病史等亦達到統計顯著意義。利用Cox比例風險模式分析則顯示,慢性腎臟疾病之無糖尿病組及慢性腎臟疾病合併糖尿病組的調整後風險比值,較兩者皆無或單純糖尿病之患者高,分別為2.22(95%信賴區間為1.43-3.44)及3.34(95%信賴區間為2.17-5.13)。進一步分析顯示,相對於糖尿病,慢性腎臟疾病為全死因死亡率之主要預後因子。 結論:本研究證實慢性腎臟疾病為急性心肌梗塞短期及長期預後之主要預測因子。 | zh_TW |
dc.description.abstract | Introduction:This study aimed to explore the combined impact of diabetes mellitus (DM) and chronic kidney disease (CKD) on short-term and long-term all-cause mortality in patients with acute myocardial infarction (AMI).
Methods:This is a prospective cohort AMI registry conduced in Cardiology Division of Cardiovascular Medical Center in Far Eastern Memorial Hospital which is located in New Taipei City, Taiwan. Database are constructed by the study coordinators and nurse practitioners according to medical records, and quality control by a cardiologist is performed every month. The primary endpoint is follow-up all-cause mortality. The data stratified by CKD and DM, univariate analysis and Cox proportional hazards model were used to evaluate the impacts in 30-day, 1- and 2-year all-cause mortality. Result:Between 2005 and 2013, a total of 2259 AMI patients were recruited. Mean follow-up duration was 1.69 ± 0.23 years. In the univariable analysis, the hazard ratio(HR)for CKD was 2.11 (95% confidence interval (CI) 1.66-2.69) in 30-day, and 6.07 (95% CI 4.67-7.92) in 2-year all-cause mortality. As for DM, HR was 1.81(95% CI 1.33-2.46)in 30-day, and 6.07(95% CI 4.67-7.92)in 2-year all-cause mortality (all P<0.05). Other prognostic factors including smoking, hypertension, atrial fibirllaiton, history of coronary artery disease or stroke, all reached statistical significance. Subjects with either CKD or DM had significantly higher risk of all-cause mortality than who without. Cox proportional hazards model showed significantly higher adjusted HRs of CKD only, or with DM and CKD were 2.22 (95% confidence interval (CI) 1.43-3.44) and 3.34 (95% CI 2.17-5.13), respectively, compared to subjects with neither DM and CKD, or DM only. Our findings support a positive association with CKD in short-term and long-term prognosis in patients with AMI. Conclusion:This study confirmed that CKD, rather than DM, is a strong prognostic factor in short-term and long-term all-cause mortality in AMI. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:42:35Z (GMT). No. of bitstreams: 1 ntu-104-R01847048-1.pdf: 1406140 bytes, checksum: 69f824bbf4aef597cc9ba40e8155dc76 (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 頁次
中文摘要…………………………………………………………………………………………………………………………………I 英文摘要………………………………………………………………………………………………………………………………II 目錄………………………………………………………………………………………………………………………………………VI 表目錄………………………………………………………………………………………………………………………………VII 圖目錄 …………………………………………………………………………………………………………………………VIII 英文縮寫……………………………………………………………………………………………………………………………IX 第一章:導論………………………………………………………………………………………………………………………1 實習單位特色與簡介…………………………………………………………………………………………………………1 第二章:研究背景及相關文獻探討……………………………………………………………………………3 2.1急性心肌梗塞……………………………………………………………………………………………………………3 2.2慢性腎臟病與急性心肌梗塞之關連性與文獻回顧…………………………………………3 2.3糖尿病與急性心肌梗塞之關連性與文獻回顧…………………………………………………9 2.4 糖尿病與慢性腎臟病之關連性…………………………………………………………………………11 第三章:研究目的與研究假說……………………………………………………………………………………12 3.1研究目的………………………………………………………………………………………………………………………12 3.2研究假說………………………………………………………………………………………………………………………12 第四章:研究方法……………………………………………………………………………………………………………13 4.1研究架構………………………………………………………………………………………………………………………13 4.2研究對象………………………………………………………………………………………………………………………13 4.4研究資料內容及收集方式……………………………………………………………………………………13 4.5統計方法………………………………………………………………………………………………………………………15 4.6樣本數估計…………………………………………………………………………………………………………………17 第五章:研究結果……………………………………………………………………………………………………………18 5.1資料取得結果與基本資料分析結果…………………………………………………………………18 5.2糖尿病合併急性心肌梗塞之基本描述性資料分析結果……………………………18 5.3慢性腎臟疾病合併急性心肌梗塞之基本描述性資料分析結果………………19 5.4糖尿病與慢性腎臟疾病合併急性心肌梗塞之基本描述性資料分析結果……………………………………………………………………………………………………………………………………………21 5.5急性心肌梗塞之單變數模型分析與全死因死亡率分析結果…………………23 5.6糖尿病與慢性腎臟疾病合併急性心肌梗塞之預後指標分析結果…………24 5.7單變數模型分析影響預後之相關風險因子……………………………………………………25 第六章:討論……………………………………………………………………………………………………………………26 6.1糖尿病合併急性心肌梗塞之基本描述性資料分析結果討論…………………26 6.2慢性腎臟疾病合併急性心肌梗塞之基本描述性資料分析結果討論……28 6.3 糖尿病與慢性腎臟疾病合併急性心肌梗塞之基本描述性資料分析結果討論………………………………………………………………………………………………………………………………………30 6.4結論與未來研究方向……………………………………………………………………………………………33 參考文獻………………………………………………………………………………………………………………………………36 | |
dc.language.iso | zh-TW | |
dc.title | 慢性腎臟病與糖尿病在急性心肌梗塞病人之預後影響 | zh_TW |
dc.title | Impact of chronic kidney disease and diabetes mellitus on the prognosis in patients with acute myocardial infarction | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 吳彥雯(Yen-Wen Wu) | |
dc.contributor.oralexamcommittee | 陳文鍾(Wen-Jone Chen),洪冠予(Guan-Yu Hong),方啟泰(Chi-Tai Fang) | |
dc.subject.keyword | 急性心肌梗塞,糖尿病,慢性腎臟疾病,全死因死亡率, | zh_TW |
dc.subject.keyword | Acute myocardial infarction (AMI),Diabetes mellitus (DM),Chronic kidney disease (CKD),All-cause mortality, | en |
dc.relation.page | 64 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-02-11 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 公共衛生碩士學位學程 | zh_TW |
顯示於系所單位: | 公共衛生碩士學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 1.37 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。